We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mechanism Behind Poor Response to Immunotherapy in Some Cancers Identified

News   Aug 22, 2017 | Original story from UNC Lineberger

 
Mechanism Behind Poor Response to Immunotherapy in Some Cancers Identified

Credit: Jonathan Serody, MD, UNC Lineberger member and the Elizabeth Thomas Professor in the UNC School of Medicine

 
 
 

RELATED ARTICLES

It Is Possible to Extend Life Without Any Genetic Modification, Study Suggests

News

Given the relationship between telomeres and ageing - telomeres shorten throughout life, so older organisms have shorter telomeres -, scientists launched a study generating mice in which 100% of their cells had hyper-long telomeres.

READ MORE

Drug Treats Inflammation Related to Genetic Heart Disease

News

Johns Hopkins researchers have shed new light on the role of the immune system in the progression of arrhythmogenic cardiomyopathy (ACM) and have also discovered a drug that may help prevent ACM symptoms and progression to heart failure.

READ MORE

Targeted Therapy Could Help Children With Deadly Nerve Cancer

News

Mount Sinai researchers have discovered a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who would otherwise have no treatment options.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE